Skip to content
Aldeyra logo
  • Contact Us
  • Contact Us
  • Patients & Caregivers
    • Dry Eye Disease Symptoms & Treatment
    • Allergic Conjunctivitis Symptoms & Treatment
    • Proliferative Vitreoretinopathy Symptoms & Treatment
    • Early Access Program
    • Clinical Trials
  • Science & Technology
    • Reactive Aldehyde Species Inhibition
    • Dihydrofolate Reductase Inhibition
    • Posters & Publications
  • Pipeline & Disease Areas
    • Ocular and Inflammatory Diseases
      • Dry Eye Disease
      • Allergic Conjunctivitis
      • Proliferative Vitreoretinopathy
  • Investors & Media
    • Overview
    • Corporate Governance
      • Charters & Governance
      • Leadership Team & Board of Directors
      • Committee Composition
    • Press Releases
    • Events & Presentations
    • Analyst Coverage
    • Stock Information
    • SEC Filings
    • Investor FAQs
    • Investor Email Alerts
  • About
    • Corporate Overview
    • Leadership Team & Board of Directors
  • Careers

Posters and Presentations

Posters and Presentations
Poster Presentation of Reproxalap Activity in Three Models of Inflammation (American Academy of Allergy Asthma & Immunology 2015 Annual Meeting) – February 2015
  • PDF (389.69 KB)

February 2015

Read More
Posters and Presentations
Poster Presentation of Reproxalap Aldehyde Sequestration in Dry Human Ocular and Dermal Tissue (Society for Investigative Dermatology 2014 Annual Meeting) – May 2014
  • PDF (370.06 KB)

May 2014

Read More
Previous 1 2 3
  • Facebook
  • LinkedIn
  • Privacy Policy
  • Terms of Service
  • Sitemap
© Aldeyra Therapeutics, Inc., 2023. All Rights Reserved.